Lux Venture Partners V, LLC - 04 Feb 2026 Form 3 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Role
10%+ Owner
Signature
/s/ Josh Wolfe
Issuer symbol
EIKN
Transactions as of
04 Feb 2026
Net transactions value
$0
Form type
3
Filing time
04 Feb 2026, 21:11:47 UTC
SEC
View on sec.gov

Reporting Owners (6)

Name Relationship Address Signature Signature date CIK
Lux Venture Partners V, LLC 10%+ Owner 920 BROADWAY, 11TH FLOOR, NEW YORK /s/ Josh Wolfe 04 Feb 2026 0001698118
Wolfe Josh Director, 10%+ Owner C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE /s/ Peter Hebert 04 Feb 2026 0001830001
Hebert Peter 10%+ Owner 920 BROADWAY, 11TH FLOOR, NEW YORK Lux Ventures V, L.P., By: Lux Venture Partners V, LLC, its General Partner, By: Peter Hebert, Managing Member /s/ Peter Hebert 04 Feb 2026 0001683771
Lux Ventures V, L.P. 10%+ Owner 920 BROADWAY, 11TH FLOOR, NEW YORK Lux Venture Partners V, LLC,, By: Peter Hebert, Managing Member /s/ Peter Hebert 04 Feb 2026 0001698008
Lux Co-Invest Opportunities II, L.P. 10%+ Owner 920 BROADWAY, 11TH FLOOR, NEW YORK Lux Co-Invest Opportunities II, L.P., By: Lux Co-Invest Partners II, LLC, its General Partner, By: Peter Hebert, Managing Member /s/ Peter Hebert 04 Feb 2026 0001783916
Lux Total Opportunities, L.P. 10%+ Owner 920 BROADWAY, 11TH FLOOR, NEW YORK Lux Co-Invest Partners II, LLC, By: Peter Hebert, Managing Member /s/ Peter Hebert 04 Feb 2026 0001864658

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EIKN Series A Preferred Stock 04 Feb 2026 Common Stock 1,340,878 See footnote F1, F2
holding EIKN Series A-1 Preferred Stock 04 Feb 2026 Common Stock 1,046,827 See footnote F2, F3
holding EIKN Series A-1 Preferred Stock 04 Feb 2026 Common Stock 335,521 See footnote F3, F4
holding EIKN Series B Preferred Stock 04 Feb 2026 Common Stock 106,785 See footnote F4, F5
holding EIKN Series B Preferred Stock 04 Feb 2026 Common Stock 71,190 See footnote F5, F6
holding EIKN Series B-1 Preferred Stock 04 Feb 2026 Common Stock 709,234 See footnote F4, F7
holding EIKN Series B-1 Preferred Stock 04 Feb 2026 Common Stock 472,822 See footnote F6, F7
holding EIKN Series C Preferred Stock 04 Feb 2026 Common Stock 40,677 See footnote F6, F8
holding EIKN Series C-1 Preferred Stock 04 Feb 2026 Common Stock 194,510 See footnote F6, F9
holding EIKN Series D Preferred Stock 04 Feb 2026 Common Stock 1,376,566 See footnote F6, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Upon the closing of the Issuer's initial public offering ("IPO"), all shares of Series A Preferred Stock will be converted into shares of Common Stock of the Issuer.
F2 These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. Peter Hebert and Josh Wolfe, a member of our board of directors (the "Individual Lux Managers"), are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein.
F3 The Series A-1 Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Upon the closing of the Issuer's IPO, all shares of Series A-1 Preferred Stock will be converted into shares of Common Stock of the Issuer.
F4 These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. The Individual Lux Managers are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
F5 The Series B Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Upon the closing of the Issuer's IPO, all shares of Series B Preferred Stock will be converted into shares of Common Stock of the Issuer.
F6 These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein.
F7 The Series B-1 Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Upon the closing of the Issuer's IPO, all shares of Series B-1 Preferred Stock will be converted into shares of Common Stock of the Issuer.
F8 The Series C Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Upon the closing of the Issuer's IPO, all shares of Series C Preferred Stock will be converted into shares of Common Stock of the Issuer.
F9 The Series C-1 Preferred Stock is convertible into Common Stock on a 1-for-7.4578 basis and has no expiration date. Upon the closing of the Issuer's IPO, all shares of Series C-1 Preferred Stock will be converted into shares of Common Stock of the Issuer.
F10 The Series D Preferred Stock is convertible into Common Stock on a 1-for 7.4578 basis and has no expiration date. Upon the closing of the Issuer's IPO, all shares of Series D Preferred Stock will be converted into shares of Common Stock of the Issuer.